3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with 1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one in 1 studies
Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one) | Trials (1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one) | Recent Studies (post-2010) (1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one) |
---|---|---|---|---|---|
166 | 8 | 81 | 5 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chokchaisiri, R; Chuprajob, T; Lin, Y; Lu, X; Shen, X; Sornkaew, N; Suksamrarn, A; Wang, F; Wang, P; Wongkrajang, K; Yang, L; Yang, N; Zhang, G; Zhou, Z | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and 1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one
Article | Year |
---|---|
Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Diarylheptanoids; Janus Kinase 2; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Sepsis; STAT3 Transcription Factor | 2022 |